Atezolizumab + bevacizumab in hepatocellular carcinoma (HCC): Safety and clinical activity results from a phase Ib study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. ix47
Main Authors Lee, K.-H., Hsu, C.-H., Lee, M.S., Ryoo, B.-Y., Verret, W., He, A.R., Kwan, A., Liu, B., Iizuka, K., Stein, S.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2018
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy432.002